[ 목 차 ]

○ 화장품산업 동향 분석

 - 제1장 연구 개요

 - 제2장 세계 화장품산업 동향 분석

 - 제3장 국내 화장품산업 동향 분석

○ 참고문헌

 part 01 유치사업 개요

Ⅰ. 외국인환자 유치지원 사업 근거 ····································································· 2
Ⅱ. 외국인환자 유치 행위 범위 ············································································ 3
Ⅲ. 외국인환자 유치기관 등록제도 ······································································· 5

part 02 2018 유치실적 조사결과

Ⅰ. 외국인환자 통계조사 개요 ············································································ 10
Ⅱ. 유치기관 조사 현황 ······················································································· 13
Ⅲ. 외국인환자 유치 현황 총괄 ·········································································· 15

part 03 그래프로 보는 유치사업

Ⅰ. 외국인환자 유치기관 활동 현황 ·································································· 28
Ⅱ. 의료기관 유형별 외국인환자 진료 현황 ····················································· 29
Ⅲ. 외국인환자 유치 지역별 활동 현황 ····························································· 30
Ⅳ. 외국인환자의 국가별･성별･연령별 분포 ····················································· 31
Ⅴ. 외국인환자의 진료과별･질환별 분포 ··························································· 33

part 04 주요 국가별 특성

Ⅰ. 중국 ·················································································································· 38
Ⅱ. 미국 ·················································································································· 42
Ⅲ. 일본 ·················································································································· 48
Ⅳ. 러시아 ·············································································································· 52
Ⅴ. 몽골 ·················································································································· 56
Ⅵ. 동남아시아 ······································································································ 60
Ⅶ. 중앙아시아 ······································································································ 65
Ⅷ. 중동 ·················································································································· 70

part 05 의료이용 유형별 특성

Ⅰ. 의료기관 유형별 현황 ··················································································· 76
Ⅱ. 의료기관 소재지별 현황 ················································································ 88

06 부 록

차례

Focus On 해외 보건의료정보 정책 동향

유럽 일반데이터보호규정(GDPR)을 통한 바이오헬스산업 혁신방향 ···················2

미국 캘리포니아 소비자프라이버시법 시행에 따른 보건산업분야 대응방안 ··········8

중국의 의료정보 정책 및 산업 동향 ································································14

Trend Watch

건강친화환경 조성과 건강친화기업인증제 도입 ···············································26

정밀의료 현황과 유전정보 관련 국제 논의 ······················································31

의료기기산업법 제정과 법령에 따른 주요 지원제도 ··········································37

Overseas Trends

[중국] 양로산업 현황과 전망, 그리고 기회 ······················································44

[중동] UAE 보건의료분야의 블록체인 기술 적용 ·············································49

[CIS] 카자흐스탄 의약품 시장 현황과 주요정책 ··············································56

[영국･일본] 최신 정책 동향 ···········································································68

KHIDI STAT

목차

1. 서론 ························································································· 1

2. 연구중심병원 현황 ······························································· 7

3. 해외병원 기술사업화 동향 ··············································· 65

4. 연구중심병원의 공공성 확보 ········································· 171

5. 산학협력단과 산병협력단 ··············································· 195

6. 연구중심병원 인증제 및 인증기준(안) ························ 239

7. 참고문헌 ··············································································· 275

제1장 개요 / 1
1. 배경 및 목적 ·················································································· 1
2. 내용 ································································································· 2
제2장 디지털헬스케어 개요 / 3
1. 디지털헬스케어 정의 ································································· 3
2. 디지털헬스케어 분류 ·································································· 8
3. 디지털헬스케어 향후 전망 ························································ 9
제3장 국내 디지털헬스케어 현황 / 20
1. 개요 ································································································· 20
2. 디지털헬스케어 서비스 사례 분석(국내 시범사업 중심) ···21
3. 디지털헬스케어 기업 현황 ························································ 38
4. 디지털헬스케어 법⋅제도 현황 ··················································· 41
5. 소결 ··································································································· 47

제4장 국외 디지털헬스케어 현황 / 49

제5장 디지털헬스케어 활성화 전략 / 332
1. 국내 디지털헬스케어 활성화 ···················································332
2. 국외 디지털헬스케어 진출 활성화 ········································ 334
부록 / 343

<차례>

제1장 기획개요 / 1

제2장 의약품 시장 동향 / 6

제3장 의약품 정책 동향 / 25

제4장 독일 의약품 규제 일반 / 33

제5장 판매 및 유통, 약가관리, 약물감시 / 112

-목차-

제1장 조사 개요

제2장 조사 결과 요약

제3장 의료서비스 결과 분석

제4장 관광서비스 결과 분석

별첨. 설문지

한국보건산업진흥원에서 발간한 "KHIDI 바이오헬스 리포트" 입니다.

- 목 차 -

Focus On 보건의료 연구개발, 병원의 역할과 과제

병원 중심의 보건산업 혁신 및 활성화 방안 .................................4

보건의료 연구개발 관련 법제의 쟁점과 동향...............................11

국내 바이오클러스터 활성화를 위한 제언....................................17

Trend Watch

모바일 건강관리 서비스 시장의 현황과 미래24

북한의 보건의료 현황과 개선방안의 모색...................................31

나고야의정서 현황 및 보건산업계 대응......................................39

보건의료 서비스의 일자리 트렌드와 전망...................................44

디지털과 의료의 만남, 디지털 치료제(Digital Therapeutics).......49

Overseas Trends

Global Issues.........................................................................62

Global Conference.................................................................93

KHIDI STAT

2018년도 상반기 보건산업 통계................................................104